5Ladurner G,Iliff LD,Lechner H.Clinical factors associated with dementia in ischaemic stroke[J].J Neurol Neurosurg Psychiatry,1982,45(2):97-101.
6Sawada H,Ibi M,Kihara T,et al.Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons[J].FASEB J,2000,14(9):1202-1214.
7Gantier R,Gilbert D,Dumanchin C,et al.The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta[J].Neurosci Lett,2000,283(3):217-220.
8Ballard CG.Advances in the treatment of Alzheimer's disease:benefits of dual cholinesterase inhibition[J].Eur Neurol,2002,47(1):64-70.
二级参考文献16
1[1]Tamaoka A,Kondo T,Odaka A,et al. Biochemical evidence for the long-tail form (A beta1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease[J]. Biochem Biophys Res Commun,1994,205:834-842.
2[2]Adler M,Coronel C,Shelton E,et al. Increased gene expression of Alzheimer disease β-amyloid precursor protein in senecent cultured fibroblasts[J]. Proc Natl Acad Sci USA,1991,88:16-20.
3[3]Mitsunaga Y,Takahashi K,Tabira T,et al. Assignment of a familial Alzheimer's disease locus between D14S289 and D14S53[J]. Lancet,1994,344:1154-1155.
4[4]Tanahashi H,Mitsunaga Y,Takashima K,et al. Missense mutation of S182gene in Japanese familial Alzheimer's disease[J]. Lancet,1995,346: 440-441.
5[5]Rossor MN,Fox NC,Beck J,et al. Imcomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presemilin-1 gene mutation[J]. Lancet,1996,347:1560-1561.
6[6]Levy-Lahad E,Wasco W,Poorkaj P,et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus[J]. Science,1995,269:973-977.
7[7]Okuizumi K,Onodera O,Namba Y,et al. Genetic association of very low density lipoprotein(VLDL) receptor gene with sporadic Alzheimer's disease[J]. Nature Genet,1995,11:207-209.
8[8]Warrant Devrieze F,Derez Tur J,Lambert JC,et al. Association between the low density lipoprotein receptor-related protein(LRP) and Alzheimer disease[J]. Neurosci Lett,1997,277:68-70.
10[10]Ueda K,Saitoh T,Mori H. Tissue-dependent alternative splicing of messenger-RNA for NACP,the precursor of non-A-β component of Alzheimer's desease amyloid[J]. Biochem Biophys Res Commun,1994,205:1366-1372.
4Do VH, Martinez CO, Martinez JL, et al. Long-term potentiation in direct perforant path projections to the hippocampal CA3 region in vivo[J].J Neurophysiol, 2002 ; 87 ( 2 ) :669-78.
5Yao Y, Chinnici C, Tang H, et al. Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis [ J ]. J Neuroinflam ,2004 ; 1 ( 1 ) :21.
